AnalystsJason N. ButlerJason N. Butler's Stock Forecasts
AnalystsJason N. Butler
Sectors:
Industries:
Analyst Ranking
Bottom 21%
#4147 out of 5185 analysts
Average Return
-1.77%
Win Rate
50%5 out of 10
Risk vs Reward
Poor
Good
Jason N. Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Precigen IncPGEN | +39.44% | $3.22 | $4.49 | 2025-08-19 - 2026-01-30 | Buy |
Abivax SaABVX | +35.55% | $82.00 | $111.15 | 2025-09-25 - 2026-01-30 | Buy |
Cytokinetics IncCYTK | +27.35% | $49.62 | $63.19 | 2025-09-02 - 2026-01-30 | Buy |
Rapport Therapeutics IncRAPP | +3.70% | $25.66 | $26.61 | 2025-11-07 - 2026-01-30 | Buy |
Acadia Pharmaceuticals IncACAD | +2.99% | $24.40 | $25.13 | 2025-08-07 - 2026-01-30 | Buy |
Jason N. Butler Analyst Color
Get additional color on Jason N. Butler's coverage of popular stocks
Jason N. Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Achieve Life Sciences IncACHV | 1 | Buy | $19.00 | +354.55% | Initiates Coverage On | 2 months ago |
Rapport Therapeutics IncRAPP | 1 | Buy | $80.00 | +200.64% | Maintains | 3 months ago |
Terawulf IncWULF | 1 | Buy | $22.00 | +64.55% | Maintains | 3 months ago |
Rezolute IncRZLT | 1 | Buy | $17.00 | +408.98% | Maintains | 3 months ago |
Abivax SaABVX | 1 | Buy | $114.00 | +2.56% | Maintains | 4 months ago |
Cormedix IncCRMD | 1 | Buy | $22.00 | +183.51% | Reiterates | 5 months ago |
Cytokinetics IncCYTK | 1 | Buy | $78.00 | +23.44% | Reiterates | 5 months ago |
Precigen IncPGEN | 1 | Buy | $8.00 | +78.17% | Maintains | 5 months ago |
Zevra Therapeutics IncZVRA | 1 | Buy | $18.00 | +100.00% | Maintains | 6 months ago |
Acadia Pharmaceuticals IncACAD | 1 | Buy | $35.00 | +39.28% | Maintains | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.